Company

Skye Bioscience Inc.

Biotechnology Research 12250 El Camino Real Drive 18 employees SKYE

Employees: 18
Contacts: 3
Emails: 3
Phones: 2

emeraldbio.life LinkedIn

Skye Bioscience Inc. Overview

Headquarters: 12250 El Camino Real Drive
Website: emeraldbio.life
Industry: Biotechnology Research
Employees: 18
Founded: 2011
Stock Symbol: SKYE
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Provider jobs

About Skye Bioscience Inc.

Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye plans to start a Phase 2 clinical trial in obesity in Q3 2024 for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, comparing monotherapy and combination arms of nimacimab and a GLP-1R agonist (Wegovy®).

Skye Bioscience Inc. Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Skye Bioscience Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Roger Ferrini, Phd, PMP, Rac-Drugs	Associate Director of Development	Encinitas, California, United States	Email Phone
Punit Dhillon	President & CEO at Skye Bioscience, Inc.	San Diego, California, United States	Email
Annalisa Jenkins			View
Jeni Fernando	Ea & Office Lead	San Francisco Bay Area, United States	Email Phone